Funding
Grant | Dates | Title | Association |
---|---|---|---|
IDSEP100006-01-00 (B. Tarbet - PI) | 09/30/2010 - 09/29/2015 | Influenza Vaccine Biomanufacturing Training | NIAID/NIH |
HHSN272201100019I/HHSN27200016/B23, (D. Smee - PI) | 03/01/2016 - 09/30/2016 | Zika Antiviral Screening Assays | NIAID/NIH |
HHSN272201100019I/HHSN27200015/B22, (D. Smee - PI) | 09/30/2015 - 09/29/2016 | Comprehensive Viral Screening Panel | NIAID/NIH |
HHSN272201100019I/HHSN27200014/B21, (D. Smee - PI) | 07/20/2015 - 07/19/2016 | In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses | NIAID/NIH |
HHSN272201100019I/HHSN27200013/B20, (D. Smee - PI) | 10/01/2014 - 09/30/2015 | Supplement to Comprehensive Panel for Viruses | NIAID/NIH |
HHSN272201100019I/HHSN27200012/B19, (D. Smee - PI) | 09/01/2014 - 08/31/2015 | Ebola Replicon Screen | NIAID/NIH |
HHSN272201100019I/HHSN27200011/B18, (D. Smee - PI) | 10/01/2014 - 09/30/2015 | Ebola, Enterovirus-68 and Enterovirus-71 Screens | NIAID/NIH |
HHSN272201100019I/HHSN27200010/B17, Task B17 (D. Smee - PI) | 09/01/2014 - 08/30/2015 | In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses | NIAID/NIH |
HHSN272201100019I/HHSN27200009/B16, Task B16 (D. Smee - PI) | 10/01/2014 - 09/30/2015 | Comprehensive Panel for Viruses | NIAID/NIH |
HHSN272201100019I/, Task B13 (D. Smee - PI) | 09/01/2013 - 08/31/2014 | In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses | NIAID/NIH |
HHSN272201100019I/HHSN27200008/B12, Task B12 (D. Smee - PI) | 10/01/2013 - 09/30/2014 | Comprehensive Panel for Viruses | NIAID/NIH |
HHSN272201100019I/HHSN27200006/B10, Task B10 (D. Smee - PI) | 10/01/2011 - 09/30/2012 | In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses | NIAID/NIH |
HHSN272201100019I/HHSN27200004/B09, Task B09 (D. Smee - PI) | 10/01/2011 - 09/30/2012 | Comprehensive Panel for Viruses | NIAID/NIH |
HHSN272201100019I/HHSN27200003/B07, Task B07 (D. Smee - PI) | 10/01/2011 - 11/30/2012 | Comprehensive Viruses Panel 2 | NIAID/NIH |
HHSN272201100019I/HHSN27200002/B05, Task B05 (D. Smee - PI) | 10/01/2011 - 09/30/2012 | Respiratory Panel for Viruses | NIAID/NIH |
HHSN272201100019I/HHSN27200001/B01, Task B01 (D. Smee - PI) | 10/01/2011 - 09/30/2012 | In Vitro Assessment for Antimicrobial Activity | NIAID/NIH |
HHSN272201000039I/HHSN27200015/A90, (J. Morrey - PI) | 01/11/2016 - 01/10/2017 | Small Animal Models for Biodefense Viruses | NIAID/NIH |
HHSN272201000039I/HHSN27200015/A87, (J. Morrey - PI) | 09/15/2015 - 09/14/2016 | Mouse Models for Evaluation of Influenza Vaccines and Vaccination Strategies | NIAID/NIH |
HHSN272201000039I/HHSN27200014/A86, (J. Morrey - PI) | 09/15/2015 - 9/14/2016 | Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential | NIAID/NIH |
HHSN272201000039I/HHSN27200013/A79, (J. Morrey - PI) | 08/30/2015 - 08/29/2017 | Mouse Model Development of Enteroviruses EV-D68 and EV-71 for Therapeutics | NIAID/NIH |
HHSN272201000039I/HHSN27200012/A66 Task A66 (J. Morrey - PI) | 09/09/2013 - 09/08/2014 | Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics | NIAID/NIH |
HHSN272201000039I/HHSN27200011/A59 Task A59 (J. Morrey - PI) | 09/09/2013 - 09/08/2014 | Mouse Models for Orthopoxviruses | NIAID/NIH |
HHSN272201000039I, Task A57 (J. Morrey - PI) | 09/15/2013 - 03/14/2015 | Mouse Models of Medical Countermeasures Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) | NIAID/NIH |
HHSN272201000039I/HHSN27200008/A56 Task A56 (J. Morrey - PI) | 09/09/2013 - 09/08/2014 | Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics | NIAID/NIH |
HHSN272201000039I/HHSN27200008/A44 Task A44 (J. Morrey - PI) | 09/09/2013 - 09/08/2014 | Mouse Models for Low Pathogenic Seasonal and Pandemic Therapeutics | NIAID/NIH |
HHSN272201000039I/HHSN27200007/A43 Task A43 (J. Morrey - PI) | 09/09/2013 - 09/08/2014 | Mouse Models for Orthopoxviruses | NIAID/NIH |
HHSN272201000039I/HHSN27200005/A37 Task A37 (J. Morrey - PI) | 09/09/2013 - 09/08/2014 | Mouse Models for Low Pathogenic Seasonal and Pandemic Influenza Viruses for Therapeutics | NIAID/NIH |
HHSN272201000039I/HHSN27200006/A30 Task A30 (J. Morrey - PI) | 09/09/2013 - 09/08/2014 | Mouse Models for Orthopoxviruses | NIAID/NIH |
HHSN272201000039I, Task A21 (J. Morrey - PI) | 01/19/2011 - 01/18/2016 | Small Animal Models for Biodefense Viruses and Prions | NIAID/NIH |
HHSN272201000039I, Task A19 (J. Morrey - PI) | 09/27/2010 - 09/26/2015 | Human Hepatitis B Virus (HBV) Mouse Models for Testing HBV Therapeutics | NIAID/NIH |
HHSN272201000039I, Task A15 (J. Morrey - PI) | 09/27/2010 - 09/26/2015 | Mouse Models for Evaluation of Influenza Vaccines and Adjuvants | NIAID/NIH |
5R33AI101483-04S1, (J. Morrey - PI) | 03/01/2016 - 07/31/2017 | Zika Virus Intrauterine Infection | NIAID/NIH |
5R33AI101483-04, (J. Morrey - PI) | 08/01/2015 - 07/31/2016 | Targeting Induction of Cystosolic Calcium buffers for Treatment of Viral Encephalitis | NIAID/NIH |
2U54 AI065357/ Sub-award G-7822-1 (B. Gowen - PI) | 05/01/2009 - 04/30/2014 | T-705 Pyrazine Derivative Treatment of Highly Pathogenic Arenaviral Infections | Rocky Mountain RCE/NIAID/NIH |
2U54 AI065357/ Sub-award G-7820-1 (J. Morrey - PI) | 05/01/2009 - 04/30/2014 | Treatment of Acute West Nile Virus Disease and Neurological Sequelae | Rocky Mountain RCE/NIAID/NIH |
2R44AI092916-02 (B. Tarbet - PI) | 07/01/2012 - 6/30/2014 | Robust, Defined, Animal-Free Cell Culture Medium for the Production of Vaccines | NIAID/NIH |
1R21NS090133-01A1, (J. Morrey - PI) | 07/01/2015 - 06/30/2016 | Identifying Deficits in Brainstem Respiratory Circuits During viral Encephalitis | NIAID/NIH |
1R21NS088400, (J. Morrey - PI) | 05/01/2015 - 04/30/2016 | Cellular Mechanisms of Fatal Respiratory Insuffieciency in Arboviral Encephalitis | NIAID/NIH |
1R21AI101483-01 (J. Morrey - PI) | 06/01/2012 - 05/31/2014 | Targeting Induction of Cytosolic Calcium Buffers for Treatment of Viral Encephalitis | NIAID/NIH |